KRAS and cholangiocarcinoma: Whole-exome and targeted sequencing has confirmed mutations in CCA-related genes such as TP53, KRAS, SMAD4, and genes associated with chromatin remodeling, WNT signaling, and KRAS/G protein signaling [55].